Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy

Post time Yesterday 11:45

journal：New England Journal of Medicine

Authors：David Steffin; Amy N. Courtney; Michelle Choe; Nisha Ghatwai; Magdalena A. Esparza Cerda; Ramy Sweidan; Rajdekar Dhanashree; Huimin Zhang; Natasha Lapteva; Zhuyong Mei; Bambi J. Grilley; Leonid S. Metelitsa; Helen E. Heslop; Malcolm K. Brenner; Andras Heczey

Published date：2026-9-10

DOI：10.1056/nejmc2605958

PDF link：http://www.nejm.org/doi/pdf/10.1056/NEJMc2605958

Article link：https://doi.org/10.1056/nejmc2605958

Article Source：Massachusetts Medical Society。

Remark：

Post time Yesterday 11:45

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[NEJM] Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy